about
An exploratory spatial analysis of ALS incidence in Ireland over 17.5 years (1995-July 2013).Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995-2010.Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study.EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.Multiparametric MRI study of ALS stratified for the C9orf72 genotype.Optimization of scarless human stem cell genome editing.Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing.Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis.Spinal cord markers in ALS: diagnostic and biomarker considerations.Congenital disorders of autophagy: an emerging novel class of inborn errors of neuro-metabolism.Basal ganglia involvement in amyotrophic lateral sclerosis.Cognitive changes predict functional decline in ALS: a population-based longitudinal study.Clinical presentation and prognostic indicators in 100 adults and children with neurofibromatosis 1 associated non-optic pathway brain gliomas.On the design of clone-based haplotypingA multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland.Patterns of cerebral and cerebellar white matter degeneration in ALS.Grey matter correlates of clinical variables in amyotrophic lateral sclerosis (ALS): a neuroimaging study of ALS motor phenotype heterogeneity and cortical focality.Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis.The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study.UBQLN2 mutations are not a frequent cause of amyotrophic lateral sclerosis in Ireland.Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis.Sexual dimorphism in ALS: exploring gender-specific neuroimaging signatures.Clustering of Neuropsychiatric Disease in First-Degree and Second-Degree Relatives of Patients With Amyotrophic Lateral Sclerosis.Homozygosity mapping in an Irish ALS case-control cohort describes local demographic phenomena and points towards potential recessive risk loci.Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.Analysis of the hexanucleotide repeat expansion and founder haplotype at C9ORF72 in an Irish psychosis case-control sample.Fecundity in ALSAge at onset of amyotrophic lateral sclerosis is proportional to life expectancyBlink rate in ALSProposed criteria for familial amyotrophic lateral sclerosis
P50
Q33670384-4B9B06E4-4FB5-4630-B52D-D2F9A0D843E7Q34375695-98B5C780-6AA8-4CC5-B939-8F4EE9362AADQ35859698-AFA24672-69CC-4A1F-A23F-D949E58AC49CQ36615500-204844A4-CE0E-4D10-AD05-C93CB636F4C1Q37170150-BA04E954-3109-414D-A40E-2E5D48DEDF79Q37236715-DBFC5C11-266D-4807-9203-BB2B951BF060Q37267700-DCBD7D9B-A365-44C2-B3ED-452C65DB2227Q37806860-73F1E5D3-7031-409A-9B64-8776ADB3137EQ37983648-46CF74FB-450E-4471-BA61-34DB796CB070Q38682634-EA4695DE-2449-4BE1-92E6-C1F966D6C5B6Q39318107-E534B09E-72A3-448B-94E6-B1F6F184EC71Q39440599-8651851A-B900-4D44-88C7-F90FDD8E42FDQ40167910-EC2375E2-6924-4982-A746-033D2AB09315Q40585267-AC78D6F8-67C9-4D15-9763-AA57C35EEA0DQ41637599-9A3F6EF5-0EF0-419A-8D4D-9865185DC8DDQ43226416-D91EB967-D9E3-4BEC-80C0-BAB28F812DBDQ43739867-4735F486-721F-4957-A87B-0E112203E753Q43962698-B8A2F2BC-151A-4D00-8494-6A82FADF8386Q44591084-0F77B40D-B113-4D89-98DE-B81D8C7DD2C2Q45345761-BB2BC778-5E93-40C5-9C19-2D78A76E313DQ45855781-DDDA065B-511D-4C4C-92BC-CAB2801D49D9Q45911042-96CDC682-A690-4089-8502-1F89EC477027Q47593807-439DDB27-983A-4980-B126-677F9E244E04Q50282751-4E2BABAD-0BB0-4BA7-BE4E-B2940A76E37EQ51014067-3A82FDF0-7179-433B-9E42-3BF693B44E21Q54356595-A91F592D-D4DD-464E-9258-8FCF014E6FFFQ58125343-2D365D71-C4B3-4497-8802-AFE431E1B354Q58125465-758B3FEB-AFA0-4881-A1EC-021179ACD0DDQ58145866-18F4FEDB-8C14-4772-9C80-4E7DC9317AADQ58170990-AA1A055D-623C-434C-9B21-864CD4AB83BD
P50
description
researcher ORCID ID = 0000-0001-6731-0343
@en
name
Susan Byrne
@ast
Susan Byrne
@en
Susan Byrne
@es
Susan Byrne
@nl
type
label
Susan Byrne
@ast
Susan Byrne
@en
Susan Byrne
@es
Susan Byrne
@nl
prefLabel
Susan Byrne
@ast
Susan Byrne
@en
Susan Byrne
@es
Susan Byrne
@nl
P1153
36082415500
P21
P31
P496
0000-0001-6731-0343